Physician profile
Christopher W Good
NPI 1740452085
$3,320.48
in general payments reported to CMS, 2019-2025
8 companies · $1,211 in 2025
The $1,211 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.85 · 2021: $21.28 · 2022: $129 · 2023: $628 · 2024: $1,232 · 2025: $1,211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,071.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,071.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,657.81 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $522.72 | 2019-2025 | Impella |
| Boston Scientific Corporation | $355.67 | 2024-2025 | Farapulse, Watchman Flx |
| Abbott Laboratories | $333.59 | 2022-2024 | Mitraclip, Portico |
| Medtronic, INC. | $271.24 | 2021-2023 | Harmony, Corevalve Evolut R |
| Impulse Dynamics (USA) INC. | $89.27 | 2024 | Optimizer |
| Amgen INC. | $46.68 | 2024-2025 | Repatha |
| Medtronic USA, INC. | $43.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Good listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.